Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Deinove SA Creates Subsidiary for its Antibiotics Program


Thursday, 21 Mar 2013 12:36pm EDT 

Deinove SA announced that it has established a dedicated subsidiary, DEINOBIOTICS, to accelerate the development of its antibiotics program. The Company owns 49% of the new entity and holds the right to buy back the outstanding shares. 

Related Company News

Company Quote

6.14
0.06 +0.99%
4:17am EST